GrowthCurve takes majority stake in TailorMed in reported $250M deal
What's the deal? TailorMed has secured a majority investment from GrowthCurve CapitalDealroom has a profile for this one. Try Dealroom →, a New York-based private equity firm, the companies announced on November 2. GrowthCurve is taking a controlling stake in the US medication-access platform, and most existing shareholders are expected to sell their holdings. Terms were undisclosed, though Calcalist reported an estimated $250 million valuation.
What does TailorMed do? Founded in 2016, the company runs a network that connects patients to financial assistance and support programs to help them afford and stay on prescribed medications. It spans more than 950 hospitals, 4,700 clinics, and 3,100 pharmacies, and says it has supported over 75 million patients and secured more than $7.4 billion in financial assistance since 2020.
What's the endgame? GrowthCurve's experience scaling data-driven businesses "with strong network effects" will help TailorMed expand its AI-powered tools for providers, pharmacies, and patients, the firm said. Chief executive officer and co-founder Srulik Dvorsky framed the deal as a step toward "expanding our capabilities across the entire medication lifecycle."
Why it matters: GrowthCurve's Vignesh Aier, head of healthcare investing, called TailorMed "the category leader" in addressing affordability and access barriers. Director Robert Thwaits added that the company has "the largest, most scaled and diverse network in the provider-integrated patient financial assistance industry."
Leerink PartnersDealroom has a profile for this one. Try Dealroom → and TripleTree advised TailorMed on the transaction.
The signal: Investor appetite for technology that eases patients' medication costs is building. Days earlier, InTandem CapitalDealroom has a profile for this one. Try Dealroom → backed rival Atlas Health, an AI-powered affordability platform — underscoring competition in a niche where access barriers remain widespread.
Read more: finanznachrichten.de
Image credit: Generated with Gemini
